Published in Blood Weekly, May 11th, 2006
These results were accomplished using MicroIslet's proprietary encapsulation formulation, which is designed to more effectively assure immunoisolation of the encapsulated islets while preserving their access to nutrients, oxygen, and transport of low molecular weight proteins.
In other words, the insulin-producing islets were sufficiently isolated from the subjects' immune...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.